Arca
Skip to content

Blood loss

Drug research and approvals for blood loss: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 857 studies of blood loss are recruiting on ClinicalTrials.gov, Health Canada has authorized 6 drug trials for it since 2013, and FDA has 1 approved and 0 open orphan designations naming it.

  • Recruiting worldwide: 857
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 857 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
Apr 14, 2025A randomized, double-blind, multi-center, placebo-controlled, parallel-group phase 3 study to compare the efficacy, acceptability, and safety of tranexamic…TRANEXAMIC ACIDHYLORIS DEVELOPMENTS SAOngoing
Jul 18, 2024Astat: arthroplasty of the shoulder using tranexamic acid trialTRANEXAMIC ACIDDR STEPHANE PELETPending
May 13, 2024Bleeding reduction in acute and chronic kidney patients having surgery (brackets) pilot trialTRANEXAMIC ACID / DESMOPRESSINHAMILTON HEALTH SCIENCES CORPORATIONOngoing
Feb 8, 2024The effects of intraoperative tranexamic acid on perioperative bleeding in craniotomiesTRANEXAMIC ACIDDR. STEPHEN LOWNIEOngoing
Jun 27, 2019Decreasing postoperative blood loss by topical vs. intravenous tranexamic acid in open cardiac surgery (deposition) trialTRANEXAMIC ACIDHAMILTON HEALTH SCIENCES CORPORATIONOngoing
Oct 26, 2017Does intravenous tranexamic acid reduce blood loss during vaginectomy? a double-blind,TRANEXAMIC ACIDMOUNT SINAI HOSPITALClosed

FDA Orphan Designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Dec 29, 1993TrasylolFor prophylactic use to reduce perioperative blood loss and the homologous blood transfusion requirement in patients undergoing…Bayer CorporationApproved

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.